Log in

NASDAQ:BNGOBioNano Genomics Stock Price, Forecast & News

$0.45
-0.01 (-2.18 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.43
Now: $0.45
$0.47
50-Day Range
$0.30
MA: $0.38
$0.50
52-Week Range
$0.25
Now: $0.45
$4.70
Volume4.41 million shs
Average Volume7.76 million shs
Market Capitalization$16.95 million
P/E RatioN/A
Dividend YieldN/A
Beta1.4
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system comprises an instrument, chip consumables, reagents, and a suite of data analysis tools. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.49 out of 5 stars


Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BNGO
CUSIPN/A
CIKN/A
Phone858-888-7600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10.13 million
Book Value$0.11 per share

Profitability

Net Income$-29,820,000.00
Net Margins-294.32%
Return on Equity-15,207.37%

Miscellaneous

Employees77
Market Cap$16.95 million
Next Earnings Date6/18/2020 (Confirmed)
OptionableNot Optionable

Receive BNGO News and Ratings via Email

Sign-up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter.

BioNano Genomics (NASDAQ:BNGO) Frequently Asked Questions

How has BioNano Genomics' stock been impacted by COVID-19 (Coronavirus)?

BioNano Genomics' stock was trading at $0.5770 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BNGO stock has decreased by 22.2% and is now trading at $0.4490. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of BioNano Genomics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioNano Genomics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for BioNano Genomics.

When is BioNano Genomics' next earnings date?

BioNano Genomics is scheduled to release its next quarterly earnings announcement on Thursday, June 18th 2020. View our earnings forecast for BioNano Genomics.

What guidance has BioNano Genomics issued on next quarter's earnings?

BioNano Genomics issued an update on its first quarter 2020 After-Hours earnings guidance on Thursday, May, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.1-1.1 million, compared to the consensus revenue estimate of $1.9 million.

What price target have analysts set for BNGO?

3 analysts have issued 1 year price targets for BioNano Genomics' shares. Their forecasts range from $1.50 to $3.00. On average, they expect BioNano Genomics' share price to reach $2.25 in the next year. This suggests a possible upside of 401.1% from the stock's current price. View analysts' price targets for BioNano Genomics.

What are Wall Street analysts saying about BioNano Genomics stock?

Here are some recent quotes from research analysts about BioNano Genomics stock:
  • 1. According to Zacks Investment Research, "BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San Diego, United States. " (4/24/2020)
  • 2. Maxim Group analysts commented, "Bionano reported 2Q19 with revenues of $2.2M and a net loss of ($7.7M). The company ended the period with $15.3M in cash on the balance sheet." (8/9/2019)

Has BioNano Genomics been receiving favorable news coverage?

Media headlines about BNGO stock have been trending very negative on Saturday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BioNano Genomics earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutBioNano Genomics.

Who are some of BioNano Genomics' key competitors?

What other stocks do shareholders of BioNano Genomics own?

Who are BioNano Genomics' key executives?

BioNano Genomics' management team includes the following people:
  • Dr. Robert Erik Holmlin, Pres, CEO & Director (Age 51)
  • Mr. Michael J. Ward, Chief Financial Officer (Age 47)
  • Mr. Warren Robinson, Chief Commercial Officer (Age 50)
  • Mr. Mark Borodkin, Chief Operating Officer (Age 45)
  • Heather Adams, Sec.

When did BioNano Genomics IPO?

(BNGO) raised $16 million in an IPO on the week of August 20th 2018. The company issued 2,500,000 shares at $6.00-$7.00 per share. Roth Capital Partners and Maxim Group served as the underwriters for the IPO and LifeSci Capital was co-manager.

What is BioNano Genomics' stock symbol?

BioNano Genomics trades on the NASDAQ under the ticker symbol "BNGO."

How do I buy shares of BioNano Genomics?

Shares of BNGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BioNano Genomics' stock price today?

One share of BNGO stock can currently be purchased for approximately $0.45.

How big of a company is BioNano Genomics?

BioNano Genomics has a market capitalization of $16.95 million and generates $10.13 million in revenue each year. The company earns $-29,820,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis. BioNano Genomics employs 77 workers across the globe.

What is BioNano Genomics' official website?

The official website for BioNano Genomics is www.bionanogenomics.com.

How can I contact BioNano Genomics?

BioNano Genomics' mailing address is 9540 TOWNE CENTRE DRIVE SUITE 100, SAN DIEGO CA, 92121. The company can be reached via phone at 858-888-7600 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.